Glioblastoma (GBM), a very aggressive form of brain cancer with poor prognosis24, presents multiple aberrant genomic alterations of EGFR that are responsible for disrupted signaling and resistance to therapies25. The gene discussed is EGFR; the disease is glioblastoma.